Nvidia teams with biotech giants to supercharge AI drug discovery
Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with pharmaceutical and biotech heavyweights to rewire how drugs are discovered and manufactured. The company is not just selling chips into healthcare, it is embedding its platforms inside labs and data centers so that model training, simulation, and physical experimentation…